Nervive is a Delaware C-corp founded in 2013, headquartered in Akron, Ohio. Their primary product, the VitalFlow Stimulator, is a non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. The company's focus is on research, development, and commercialization of medical therapies for brain ischemia, with the aim of providing faster recovery for patients suffering from ischemia. Nervive's VitalFlow Stimulator can help address the challenge of limited access to stroke treatment, brain imaging, and proper diagnosis, as less than 5% of patients currently have access to these services.